New Alzheimer's drug targets brain connections in early safety test
NCT ID NCT05804383
Summary
This early-stage study tested the safety and side effects of an experimental drug called BMS-984923 in healthy older adults and people with early Alzheimer's disease. The main goal was to see if the drug was safe at different dose levels and to check if brain scans could detect changes in the connections between brain cells. The study involved 51 participants and was not designed to prove if the drug improves memory or thinking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spaulding Clinical Research
West Bend, Wisconsin, 53095, United States
-
Yale University
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.